APA način citiranja

Zou, C., Zhu, C., Guan, G., Guo, Q., Liu, T., Shen, S., . . . Cheng, W. (2019). CD48 is a key molecule of immunomodulation affecting prognosis in glioma. Onco Targets Ther.

Čikaški stil citiranja

Zou, Cunyi, et al. "CD48 Is a Key Molecule of Immunomodulation Affecting Prognosis in Glioma." Onco Targets Ther 2019.

MLA način citiranja

Zou, Cunyi, et al. "CD48 Is a Key Molecule of Immunomodulation Affecting Prognosis in Glioma." Onco Targets Ther 2019.